Profile data is unavailable for this security.
About the company
Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule drugs. The Company's main products include molecular building blocks and tool compounds. The Company's products also include active pharmaceutical ingredients (APIs) and intermediates. The Company also provides related services such as contract research organization (CRO) service. The Company's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The Company distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)2.05bn
- Net income in CNY103.00m
- Incorporated2006
- Employees3.37k
- LocationShanghai Haoyuan Chemexpress Co LtdBuilding 3, Lane 1999,Zhangheng Road,Pudong New AreaSHANGHAI 201203ChinaCHN
- Phone+86 2 158338205
- Fax+86 2 158955996
- Websitehttps://www.chemexpress.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guizhou Sanli Pharmaceutical Co Ltd | 1.92bn | 308.82m | 4.89bn | 2.28k | 16.32 | 3.21 | -- | 2.54 | 0.7311 | 0.7311 | 4.59 | 3.72 | 0.7844 | 2.50 | 4.26 | 843,357.60 | 12.76 | 12.39 | 19.35 | 16.72 | 70.14 | 70.45 | 16.27 | 16.31 | 1.52 | -- | 0.2486 | 25.70 | 36.10 | 17.75 | 45.42 | 21.51 | 127.48 | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 2.05bn | 103.00m | 5.02bn | 3.37k | 48.58 | 1.92 | -- | 2.44 | 0.4911 | 0.4911 | 9.79 | 12.45 | 0.4922 | 1.03 | 3.90 | 609,696.60 | 2.43 | 7.38 | 3.29 | 9.60 | 42.71 | 47.03 | 4.93 | 13.53 | 0.9905 | 3.08 | 0.3088 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
| Wuhan Keqian Biology Co Ltd | 932.75m | 309.38m | 5.28bn | 923.00 | 16.96 | 1.40 | -- | 5.66 | 0.6681 | 0.6681 | 2.01 | 8.07 | 0.2072 | 2.09 | 2.79 | 1,010,559.00 | 6.86 | 13.29 | 8.07 | 15.49 | 66.77 | 76.49 | 33.11 | 45.71 | 3.93 | -- | 0.0637 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Cisen Pharmaceutical Co Ltd | 4.31bn | 527.50m | 5.36bn | 3.40k | 10.19 | 0.9223 | -- | 1.24 | 1.16 | 1.16 | 9.49 | 12.83 | 0.6071 | 2.29 | 5.67 | 1,267,832.00 | 7.49 | 6.94 | 9.20 | 8.56 | 58.78 | 56.27 | 12.34 | 10.77 | 2.96 | -- | 0.0551 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
Data as of Sep 20 2024. Currency figures normalised to Shanghai Haoyuan Chemexpress Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management (Hong Kong) Ltd.as of 31 Jul 2024 | 7.23m | 3.53% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 4.37m | 2.13% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 4.17m | 2.04% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 3.54m | 1.73% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 2.91m | 1.42% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 1.85m | 0.90% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.79m | 0.88% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 1.56m | 0.76% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.36m | 0.66% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 854.30k | 0.42% |
More ▼
Data from 31 Dec 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.
